Malignant Myoepithelioma of Bone and Soft Tissues: Diagnostic Imaging and Histology in Relation to Prognosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

33 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-10

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to assess whether there is a correlation between imaging and histology with prognosis in patients with soft tissue and bone MC from the archives of the Rizzoli Orthopaedic Institute all the patients with a histological diagnosis of soft tissue or bone malignant myoepithelioma treated from 1998 to 2021

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Epithelioid Hemangioma of Bone And Soft Tissue

NCT03169595

Epithelioid Hemangioma of Bone Epithelioid Hemangioma

COMPLETED

Osteoarticular Tumor Characterization by Advanced Imaging

NCT02895633

Bone Tumor Soft Tissue Tumor

UNKNOWN NA

Electrochemotherapy in Musculoskeletal Tumors

NCT07323017

Bone Tumors

ACTIVE_NOT_RECRUITING

Radiomics Compared With Conventional Response Criteria for Predicting Progression of Desmoid Tumor After Cryoablation

NCT06224283

Desmoid

RECRUITING

Diagnosis and Definition of Local Involvement of Musculoskeletal Tumors: Assessment of Ultra-high Field MRI Exploration Contribution

NCT03628274

Sarcoma

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myoepithelioma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients

patients with a histological diagnosis of soft tissue or bone malignant myoepithelioma treated from 1998 to 2021.

Clinical data review

Intervention Type OTHER

review the medical records, radiological imaging, and histological data of these patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Clinical data review

review the medical records, radiological imaging, and histological data of these patients

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female patients treated at Rizzoli Orthopaedic Institute between 01 Jan 1998 and 31 Dec 2021
* Age ≥ 2 years old
* Diagnosis of soft tissue or bone malignant myoepithelioma (MC-SB)
* Patients with available clinical and imaging data